Phylogica patent allowed
Thursday, 29 September, 2005
Perth-based Phylogica (ASX:PYC) has received formal notice of allowance from the European Patent and Trademark Office for its pending patent application entitled: "Isolating biological modulators from biodiverse gene fragment libraries".
The application was filed in 2000 and protects Phylogica's core peptide library technology. Phylogica's proprietary libraries contain millions of phylomers - stable fragments of naturally occurring proteins.
"Not only are the methods for creating these libraries covered but this foundation patent application also describes methods for increasing the diversity of the libraries further," said Phylogica's scientific director Dr Paul Watt in a statement.
Phylogica has eight patent families and cases from the patent family of this recently allowed application have already been granted in Australia and allowed in the US.
Protein-based therapy helps the body remove harmful cells
Scientists have created a protein-based therapeutic tool that could change the way we treat...
Diabetes changes the structure of our hearts, study finds
Type 2 diabetes directly alters the heart's structure and energy systems, which explains why...
Beta blockers could halt triple negative breast cancer
Researchers have identified a molecular biomarker in triple negative breast cancer tumours which...